Rituximab 不优于硫唑嘌呤用于 EGPA 维持缓解
Rituximab not superior to azathioprine for EGPA remission maintenance
一项涉及 98 名成人 EGPA 患者的随机对照试验 MAINRITSEG 结果显示,利妥昔单抗与硫唑嘌呤在维持缓解方面的效果无显著差异(P = 0.38)。患者接受泼尼松 ≤7.5 mg 每日剂量治疗时,在缓解状态下的累积周数无明显区别(利妥昔单抗组 91 周 vs 硫唑嘌呤组 96 周)。
- Research Highlight
- Published: 10 November 2026
Vasculitis
Nature Reviews Rheumatology (2026) Cite this article
Results of the MAINRITSEG randomized controlled trial indicate that rituximab is no more effective than azathioprine for maintaining remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA).
The investigator-initiated trial involved 98 adults with newly diagnosed or relapsing EGPA who had achieved a state of remission within the past year. Participants were randomly allocated to receive treatment with either rituximab or azathioprine plus a standardized prednisone tapering regimen. During the 28-month study, the number of accrued weeks spent in remission while receiving prednisone at a dose of ≤7.5 mg daily was not significantly different between the rituximab and azathioprine groups (91 weeks vs 96 weeks; P = 0.38).
This is a preview of subscription content, access via your institution
Access options
Access through your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
32.70 € / 30 days cancel any time
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
39,95 €
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Author information
Authors and Affiliations
Nature Reviews Rheumatology http://www.nature.com/nrrheum/
Sarah Onuora
Authors
- Sarah Onuora
Corresponding author
Correspondence to Sarah Onuora.
About this article
Cite this article
Onuora, S. Rituximab not superior to azathioprine for EGPA remission maintenance. Nat Rev Rheumatol (2026). https://doi.org/10.1038/s41584-026-01465-4
Published: 10 November 2026
Version of record: 10 November 2026
DOI: https://doi.org/10.1038/s41584-026-01465-4
来源:Nature 健康护理主题 · nature.com